Indivior PLC Ordinary SharesINDV
± 混在資本関連度
Investigation into Indivior's merger with Supernus, where shareholders would own 56.5% of combined company; may seek better terms.
銘柄への影響 5
Biotech & Genomic Medicine
Indivior PLC Ordinary Shares
Lantheus Holdings IncLNTH
± 混在資本関連度
Investigation into Lantheus's sale to Curium for $102.50 per share plus CVRs; may seek increased consideration or disclosures.
Supernus Pharmaceuticals IncSUPN
± 混在資本関連度
Indivior's merger with Supernus is under investigation; Supernus is the acquirer, potential impact on deal terms.
Energy Transition & Power Demand
Atkore International Group IncATKR
± 混在資本関連度
Investigation into whether Atkore's sale to Prysmian at $95.00 per share is fair to shareholders; may seek increased consideration.
Prysmian SpA0NUX
± 混在資本関連度
Atkore's sale to Prysmian is under investigation; Prysmian is the acquirer, potential impact on deal terms.
テーマインパクト
カバレッジ外企業 1
Curium非上場± 混在
関連度